Sorafenib tosylate and paclitaxel induce anti-angiogenic, anti-tumour and anti-resorptive effects in experimental breast cancer bone metastases (Q85072202)
Jump to navigation
Jump to search
scientific article published on 20 September 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sorafenib tosylate and paclitaxel induce anti-angiogenic, anti-tumour and anti-resorptive effects in experimental breast cancer bone metastases |
scientific article published on 20 September 2010 |
Statements
Sorafenib tosylate and paclitaxel induce anti-angiogenic, anti-tumour and anti-resorptive effects in experimental breast cancer bone metastases (English)
Maximilian Merz
Dorde Komljenovic
Stefan Zwick
Wolfhard Semmler
Tobias Bäuerle
20 September 2010